UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Signaling cross-talk in the resistance to HER family receptor targeted therapy

Oncogene, 2014-02, Vol.33 (9), p.1073-1081

2014

Link zum Volltext

Verfügbarkeit prüfen

The EGF receptor family as targets for cancer therapy

Oncogene, 2000-12, Vol.19 (56), p.6550-6565

2000

Link zum Volltext

Verfügbarkeit prüfen

The role of the p90 ribosomal S6 kinase family in prostate cancer progression and therapy resistance

Oncogene, 2021-06, Vol.40 (22), p.3775-3785

2021

Link zum Volltext

Verfügbarkeit prüfen

The Bcl-2 apoptotic switch in cancer development and therapy

Oncogene, 2007-02, Vol.26 (9), p.1324-1337

2007

Link zum Volltext

Verfügbarkeit prüfen

MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets

Oncogene, 2015-06, Vol.34 (25), p.3226-3239

2015

Link zum Volltext

Verfügbarkeit prüfen

IAP-targeted therapies for cancer

Oncogene, 2008-10, Vol.27 (48), p.6252-6275

2008

Link zum Volltext

Verfügbarkeit prüfen

The EGF receptor family as targets for cancer therapy: New Drug Targets and Therapies for Cancer

Oncogene, 2000, Vol.19 (56), p.6550-6565

2000

Link zum Volltext

Verfügbarkeit prüfen

Bcl-2 family proteins and cancer

Oncogene, 2008-10, Vol.27 (50), p.6398-6406

2008

Link zum Volltext

Verfügbarkeit prüfen

Polo-like kinases and acute leukemia

Oncogene, 2019, Vol.38 (1), p.1-16

2019

Link zum Volltext

Verfügbarkeit prüfen

TRAIL and apoptosis induction by TNF-family death receptors

Oncogene, 2003-11, Vol.22 (53), p.8628-8633

2003

Link zum Volltext

Verfügbarkeit prüfen

Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations

Oncogene, 2014-09, Vol.33 (39), p.4724-4734

2014

Link zum Volltext

Verfügbarkeit prüfen

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer

Oncogene, 2012-04, Vol.31 (17), p.2222-2236

2012

Link zum Volltext

Verfügbarkeit prüfen

Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma

Oncogene, 2020-02, Vol.39 (9), p.2009-2023

2020

Link zum Volltext

Verfügbarkeit prüfen

Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors

Oncogene, 2018-01, Vol.37 (2), p.160-173

2018

Link zum Volltext

Verfügbarkeit prüfen

Bcl-2 family proteins as targets for anticancer drug design: New Drug Targets and Therapies for Cancer

Oncogene, 2000, Vol.19 (56), p.6627-6631

ZIWEI HUANG

2000

Link zum Volltext

Verfügbarkeit prüfen

Ionizing radiation enhances therapeutic activity of mda-7/IL-24 : overcoming radiation- and mda-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2

Oncogene, 2006-04, Vol.25 (16), p.2339-2348

2006

Link zum Volltext

Verfügbarkeit prüfen

The death effector domain protein family

Oncogene, 2003-11, Vol.22 (53), p.8634-8644

2003

Link zum Volltext

Verfügbarkeit prüfen

Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts

Oncogene, 1995-09, Vol.11 (6), p.1049-1054

1995

Link zum Volltext

Verfügbarkeit prüfen

Survivin mediates resistance to antiandrogen therapy in prostate cancer

Oncogene, 2005-04, Vol.24 (15), p.2474-2482

2005

Link zum Volltext

Verfügbarkeit prüfen

Integrin β5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways

Oncogene, 2013-06, Vol.32 (25), p.3049-3058

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer

Oncogene, 2016-04, Vol.35 (15), p.1877-1887

2016

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

Oncogene, 2008-06, Vol.27 (28), p.3944-3956

2008

Link zum Volltext

Verfügbarkeit prüfen

The oxytocin receptor signalling system and breast cancer: a critical review

Oncogene, 2020-09, Vol.39 (37), p.5917-5932

2020

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies

Oncogene, 2018-03, Vol.37 (12), p.1561-1575

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 7.564

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieOncogene

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(7.564)
Mit Volltextzugriff
(7.552)

Publikationsform

Artikel
(7.564)

Sprache

Englisch
(7.564)
Japanisch
(2.062)
Norwegisch
(3)
Russisch
(3)

Erscheinungsjahr

n.n

Thema

Oncology
(6.412)
Science & Technology
(6.181)
Biochemistry & Molecular Biology
(6.180)
Cell Biology
(6.180)
Genetics & Heredity
(6.180)
Life Sciences & Biomedicine
(6.180)
Humans
(5.482)
Tumors
(3.374)
Genetic Aspects
(3.328)
Animals
(3.084)
Cancer
(2.543)
Gene Expression
(2.539)
Biological And Medical Sciences
(2.450)
Fundamental And Applied Biological Sciences. Psychology
(2.417)
Genetics
(2.370)
Cell Line, Tumor
(2.356)
Mice
(2.311)
Health Aspects
(2.308)
Molecular And Cellular Biology
(2.305)
Cell Physiology
(2.215)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neu hinzugefügt

... seit 90 Tagen
(23)

Menü

Weitere Dienste

Einstellungen

Signaling cross-talk in the resistance to HER family receptor targeted therapy

The EGF receptor family as targets for cancer therapy

The role of the p90 ribosomal S6 kinase family in prostate cancer progression and therapy resistance

The Bcl-2 apoptotic switch in cancer development and therapy

MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets

IAP-targeted therapies for cancer

The EGF receptor family as targets for cancer therapy: New Drug Targets and Therapies for Cancer

Bcl-2 family proteins and cancer

Polo-like kinases and acute leukemia

TRAIL and apoptosis induction by TNF-family death receptors

Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer

Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma

Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors

Bcl-2 family proteins as targets for anticancer drug design: New Drug Targets and Therapies for Cancer

Ionizing radiation enhances therapeutic activity of mda-7/IL-24 : overcoming radiation- and mda-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2

The death effector domain protein family

Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts

Survivin mediates resistance to antiandrogen therapy in prostate cancer

Integrin β5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways

Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

The oxytocin receptor signalling system and breast cancer: a critical review

Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies

Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties

Aktive Filter

Suchergebnisse filtern